Review Article
Biliopancreatic Diversion: The Effectiveness of Duodenal Switch and Its Limitations
Table 3
Effect of biliopancreatic diversion with duodenal switch on dyslipidemia.
| Study
(number of patients) | Dislipidemia incidence preoperatively | Resolution of dyslipidemia | Measure of resolution |
| | Crea et al. [24] | A-Hypercholesterolemia 87% | A-Hypercholesterolemia 98% | Hypercholesterolemia/hypertriglyceridemia—Laboratory values within the normal range (not defined) | | A-Hypertriglyceridemia 53% | A-Hypertriglyceridemia 97% | | A-BPD: 287 | B-Hypercholesterolemia 85% | B-Hypercholesterolemia 99% | | B-DS: 253 | B-Hypertriglyceridemia 55% | B-Hypertriglyceridemia 99% |
| Papadia et al. [25]
| 16% | 100% | Serum cholesterol < 200 mg/dL |
| Vage et al. [35]
| 48% (on treatment) | 92% | LDL Hyperlipidemia—discontinuation of hypolipidemic agents with LDL < 2.6 mmol/L |
| Dorman et al. [36]
| | | Hyperlipidemia—not defined | | A-BPD/DS: 190 | A-54% | A-81% | | B-RYGB 139 | B-44% | B-55% |
| Prachand et al. [37]
| | | Dyslipidemia—discontinuation of the medications used for treatment with the absence of symptoms | | A-BPD/DS: 198 | A-31% | A-72% | | B-RYGB: 152 | B-36% | B-26% |
| Pata et al. [38]
| Hypercholesterolemia 87%
Hypertriglyceridemia 53% | Hypercholesterolemia 98%
Hypertriglyceridemia 96% | Laboratory values within the normal range (cholesterol 120–200 mg/dL, triglycerides < 150 mg/dL) |
|
|
BPD: biliopancreatic diversion.
DS: duodenal switch.
Medical: medical management of weight loss/comorbidities.
Tcholesterol: total cholesterol.
TG: triglycerides.
HDL: high-density lipoprotein.
LDL: low-density lipoprotein.
RYGB: Roux-en-Y gastric bypass.
|
